1. Home
  2. UA vs OGN Comparison

UA vs OGN Comparison

Compare UA & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Under Armour Inc. Class C

UA

Under Armour Inc. Class C

HOLD

Current Price

$4.34

Market Cap

1.7B

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$7.09

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UA
OGN
Founded
1996
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
UA
OGN
Price
$4.34
$7.09
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
$14.10
AVG Volume (30 Days)
4.7M
4.7M
Earning Date
02-05-2026
02-12-2026
Dividend Yield
N/A
1.15%
EPS Growth
N/A
N/A
EPS
N/A
1.91
Revenue
$5,049,070,000.00
$6,301,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.54
N/A
P/E Ratio
N/A
$3.65
Revenue Growth
N/A
N/A
52 Week Low
$3.95
$6.18
52 Week High
$7.85
$17.23

Technical Indicators

Market Signals
Indicator
UA
OGN
Relative Strength Index (RSI) 53.60 44.78
Support Level $4.07 $6.75
Resistance Level $4.44 $7.14
Average True Range (ATR) 0.13 0.25
MACD 0.03 0.01
Stochastic Oscillator 81.10 40.72

Price Performance

Historical Comparison
UA
OGN

About UA Under Armour Inc. Class C

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and Latin America. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through wholesale partners, company-owned digital channels, and approximately 450 company-owned outlet and full-price stores. The Baltimore-based firm was founded in 1996 and is led by controlling shareholder Kevin Plank.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: